Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-18

Clinical Trial Update: Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated techniques for subcutaneous administration of fluids enabled by human recombinant hyaluronidase; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hylenex (hyaluronidase)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Dehydration | Phase 4 | Status: COMPLETED | Results posted: 2011-10-18